Illuminaの簿価
Illuminaの簿価 は何ですか。
Illumina, Inc.の簿価 は7,577.63です。
簿価 の定義は何ですか。
1株当たりの帳簿価額は、会社の資産から会社の負債を差し引いた数を発行済株式数で割ったものです。
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
LSEのセクタMiscellaneousにおける簿価 の企業と比べるIllumina
Illuminaは何をしますか。
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has collaboration agreements with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer; LetsGetChecked to track COVID-19 variants in California; and Merck & Co., Inc. to develop and commercialize tests that identify genetic mutations used in the assessment of homologous recombination deficiency. The company was incorporated in 1998 and is headquartered in San Diego, California.
Illuminaと類似の簿価
- ANSYSの簿価 は7,294.00です。
- FuelCellの簿価 は7,305.41です。
- Investis SAの簿価 は7,385.18です。
- First Solarの簿価 は7,391.53です。
- La Societe Industrielle et Financiere de l'Artoisの簿価 は7,565.32です。
- Enea AB (publ)の簿価 は7,565.43です。
- Illuminaの簿価 は7,577.63です。
- PDL Biopharma Incの簿価 は7,581.60です。
- Maruwa Coの簿価 は7,585.88です。
- Mountview Estates P.L.Cの簿価 は7,677.82です。
- Maharashtra Scootersの簿価 は7,679.04です。
- N.B.I. Industrial Financeの簿価 は7,696.01です。
- CARBO Ceramicsの簿価 は7,717.17です。